← Open Payments lookup

STEVEN MCCULLOUGH: Open Payments

NPI 1992791925 · PANDORA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,400 in 118 payments from 23 companies in 2025. Trend: 2023 $2,195 · 2024 $2,614 · 2025 $2,400

Food & beverage: $2,400
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP15$408
Lilly USA, LLC15$385
ABBVIE INC.21$315
Novo Nordisk Inc16$208
Otsuka America Pharmaceutical, Inc.10$179
Kowa Pharmaceuticals America, Inc.7$168
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$149
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$138
Abbott Laboratories4$76
Boston Scientific Corporation2$62

Products named: AIRSUPRA, MOUNJARO, REXULTI, ZORYVE, XIFAXAN, VRAYLAR, CAPLYTA, ZEPBOUND.

Industry payments across OH — which companies pay providers there.